Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AUDIOEYE INCAEYE · Entity 6844 | Director | October 01, 2026 | October 03, 2026 |
| IRADIMED CORPIRMD · Entity 4896 | Director | December 11, 2025 | December 15, 2025 |
| NATUS MEDICAL INCBABY · Entity 125256 | Director · President and CEO | April 30, 2018 | May 02, 2018 |
| OSI SYSTEMS INCOSIS · Entity 4160 | Director | August 20, 2026 | August 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AUDIOEYE INC
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 218,684 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 1,000 · Balance 218,684 F1: The securities relate to a quarterly grant of shares of common stock under the AudioEye, Inc. 2020 Equity Incentive Plan, which shares were fully vested on the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: The securities relate to a quarterly grant of shares of common stock under the AudioEye, Inc. 2020 Equity Incentive Plan, which shares were fully vested on the grant date.
IRADIMED CORP
Report date December 11, 2025 · Filed December 15, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,932 |
Reported balance
After 2025-12-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-12-11 · Grant · Acquired 1,026 · Balance 1,932 F1: Restricted stock units convert into common stock on a one-for-one basis. F2: On December 11, 2025, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 11, 2026. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert into common stock on a one-for-one basis.
F2: On December 11, 2025, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 11, 2026. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
NATUS MEDICAL INC
Report date April 30, 2018 · Filed May 02, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.001 par value per shareSEC Table I · non-derivative | Direct | 639,257 |
Ending reported balance
After 2018-04-30 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2018-04-30 · Exercise / conversion · Acquired 47,500 · Balance 686,757 Row 2 · 2018-04-30 · Sale · Disposed 47,500 · Balance 639,257 F1: This transaction was executed in multiple trades at prices ranging from $32.90 to $34.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 3 · 2018-04-30 · Exercise / conversion · Acquired 76,827 · Balance 716,084 Row 4 · 2018-04-30 · Sale · Disposed 76,827 · Balance 639,257 F2: This transaction was executed in multiple trades at prices ranging from $33.05 to $33.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 5 · 2018-04-30 · Exercise / conversion · Acquired 35,673 · Balance 674,930 Row 6 · 2018-04-30 · Sale · Disposed 35,673 · Balance 639,257 F3: This transaction was executed in multiple trades at prices ranging from $32.65 to $33.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Nonqualified Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $10.69 · Expires 2018-06-07 | Direct | 112,500 |
Reported balance
After 2018-04-30 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2018-04-30 · Exercise / conversion · Disposed 47,500 · Balance 112,500 |
| Nonqualified Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $10.69 · Expires 2018-06-07 | Direct | 35,673 |
Reported balance
After 2018-05-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2018-05-01 · Exercise / conversion · Disposed 76,827 · Balance 35,673 |
| Nonqualified Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $10.69 · Expires 2018-06-07 | Direct | 0 |
Reported balance
After 2018-05-02 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2018-05-02 · Exercise / conversion · Disposed 35,673 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $32.90 to $34.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: This transaction was executed in multiple trades at prices ranging from $33.05 to $33.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $32.65 to $33.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
OSI SYSTEMS INC
Report date August 20, 2026 · Filed August 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,295 |
Reported balance
After 2026-08-20 transaction · row 1
1 source rowRow 1 · 2026-08-20 · Tax withholding · Disposed 90 · Balance 5,295 F1: Pursuant with a net settlement, shares of stock were tendered to pay for the tax withholding. No shares of stock were sold. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant with a net settlement, shares of stock were tendered to pay for the tax withholding. No shares of stock were sold.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Caesars Entertainment, Inc.
Report date July 20, 2020 · Filed July 23, 2020
Section 16 reporting ended · disclosed 2020-07-23. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 128,082 |
Ending reported balance
After 2020-07-20 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2020-07-20 · Exercise / conversion · Acquired 9,256 · Balance 91,256 F1: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with Eldorado Resorts, Inc. (n/k/a Caesars Entertainment, Inc., the "Company"), all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. Row 2 · 2020-07-20 · Exercise / conversion · Acquired 17,980 · Balance 109,236 F2: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. Row 3 · 2020-07-20 · Exercise / conversion · Acquired 6,984 · Balance 116,220 F3: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. Row 4 · 2020-07-20 · Exercise / conversion · Acquired 4,612 · Balance 120,832 F4: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. Row 5 · 2020-07-20 · Exercise / conversion · Acquired 4,305 · Balance 125,137 F5: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. Row 6 · 2020-07-20 · Exercise / conversion · Acquired 2,945 · Balance 128,082 F6: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2020-07-20 | Direct | 0 |
Reported balance
After 2020-07-20 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2020-07-20 · Exercise / conversion · Disposed 9,256 · Balance 0 F1: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with Eldorado Resorts, Inc. (n/k/a Caesars Entertainment, Inc., the "Company"), all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2020-07-20 | Direct | 0 |
Reported balance
After 2020-07-20 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2020-07-20 · Exercise / conversion · Disposed 17,980 · Balance 0 F2: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2020-07-20 | Direct | 0 |
Reported balance
After 2020-07-20 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2020-07-20 · Exercise / conversion · Disposed 6,984 · Balance 0 F3: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2020-07-20 | Direct | 0 |
Reported balance
After 2020-07-20 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2020-07-20 · Exercise / conversion · Disposed 4,612 · Balance 0 F4: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2020-07-20 | Direct | 0 |
Reported balance
After 2020-07-20 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2020-07-20 · Exercise / conversion · Disposed 4,305 · Balance 0 F5: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2020-07-20 | Direct | 0 |
Reported balance
After 2020-07-20 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2020-07-20 · Exercise / conversion · Disposed 2,945 · Balance 0 F6: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with Eldorado Resorts, Inc. (n/k/a Caesars Entertainment, Inc., the "Company"), all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock.
F2: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock.
F3: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock.
F4: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock.
F5: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock.
F6: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 05, 2021 Filed Nov 10, 2021 22:09 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 5,501 | $38.25 | $210,413.25 |
DisclosureSEC source: 0000898432-21-000723 · form4.xml · nonDerivative · entry 2 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,268 F2 · price: This transaction was executed in multiple trades at prices ranging from $38.25 to $38.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 05, 2021 Filed Nov 10, 2021 22:09 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantCommon Stock | 5,501 | $1.48 | $8,141.48 |
DisclosureSEC source: 0000898432-21-000723 · form4.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,769 F1 · price: This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 15:29 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionStock Options (Right to Buy) · Derivative | 12,285 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0000898432-21-000712 · form4.xml · derivative · entry 9 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,214 Underlying: Common Stock · 12,285 shares Expires 2023-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 15:29 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 12,285 | $38.45 | $472,402.48 |
DisclosureSEC source: 0000898432-21-000712 · form4.xml · nonDerivative · entry 6 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,268 F4 · price: This transaction was executed in multiple trades at prices ranging from $38.20 to $39.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 15:29 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantCommon Stock | 12,285 | $1.48 | $18,181.80 |
DisclosureSEC source: 0000898432-21-000712 · form4.xml · nonDerivative · entry 5 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,553 F1 · price: This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 15:29 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionStock Options (Right to Buy) · Derivative | 16,735 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0000898432-21-000712 · form4.xml · derivative · entry 8 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,499 Underlying: Common Stock · 16,735 shares Expires 2023-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 15:29 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 16,735 | $38.01 | $636,037.10 |
DisclosureSEC source: 0000898432-21-000712 · form4.xml · nonDerivative · entry 4 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,268 F3 · price: This transaction was executed in multiple trades at prices ranging from $38.00 to 38.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 15:29 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantCommon Stock | 16,735 | $1.48 | $24,767.80 |
DisclosureSEC source: 0000898432-21-000712 · form4.xml · nonDerivative · entry 3 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,003 F1 · price: This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 02, 2021 Filed Nov 5, 2021 15:29 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionStock Options (Right to Buy) · Derivative | 4,766 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0000898432-21-000712 · form4.xml · derivative · entry 7 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,234 Underlying: Common Stock · 4,766 shares Expires 2023-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 02, 2021 Filed Nov 5, 2021 15:29 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 4,766 | $38.01 | $181,166.62 |
DisclosureSEC source: 0000898432-21-000712 · form4.xml · nonDerivative · entry 2 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,268 F2 · price: This transaction was executed in multiple trades at prices ranging from $38.00 to 38.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 02, 2021 Filed Nov 5, 2021 15:29 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantCommon Stock | 4,766 | $1.48 | $7,053.68 |
DisclosureSEC source: 0000898432-21-000712 · form4.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,034 F1 · price: This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 11, 2021 Filed Aug 11, 2021 22:21 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionStock Options (Right to Buy) · Derivative | 7,891 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0000898432-21-000601 · form4.xml · derivative · entry 9 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,891 shares Expires 2022-11-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option, representing a right to purchase a total of 17,500 shares, was granted on 11/20/2012 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 11, 2021 Filed Aug 11, 2021 22:21 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 7,891 | $35.20 | $277,725.32 |
DisclosureSEC source: 0000898432-21-000601 · form4.xml · nonDerivative · entry 6 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,268 F4 · price: This transaction was executed in multiple trades at prices ranging from $34.85 to 35.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 11, 2021 Filed Aug 11, 2021 22:21 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantCommon Stock | 7,891 | $1.29 | $10,145.46 |
DisclosureSEC source: 0000898432-21-000601 · form4.xml · nonDerivative · entry 5 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,159 F1 · price: This option, representing a right to purchase a total of 17,500 shares, was granted on 11/20/2012 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 22:21 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionStock Options (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0000898432-21-000601 · form4.xml · derivative · entry 8 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,891 Underlying: Common Stock · 5,000 shares Expires 2022-11-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option, representing a right to purchase a total of 17,500 shares, was granted on 11/20/2012 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 22:21 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 5,000 | $35.72 | $178,619.50 |
DisclosureSEC source: 0000898432-21-000601 · form4.xml · nonDerivative · entry 4 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,268 F3 · price: This transaction was executed in multiple trades at prices ranging from $35.30 to 36.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 22:21 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantCommon Stock | 5,000 | $1.29 | $6,428.50 |
DisclosureSEC source: 0000898432-21-000601 · form4.xml · nonDerivative · entry 3 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,268 F1 · price: This option, representing a right to purchase a total of 17,500 shares, was granted on 11/20/2012 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 22:21 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionStock Options (Right to Buy) · Derivative | 4,609 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0000898432-21-000601 · form4.xml · derivative · entry 7 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,891 Underlying: Common Stock · 4,609 shares Expires 2022-11-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option, representing a right to purchase a total of 17,500 shares, was granted on 11/20/2012 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 22:21 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 4,609 | $35.83 | $165,125.26 |
DisclosureSEC source: 0000898432-21-000601 · form4.xml · nonDerivative · entry 2 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,268 F2 · price: This transaction was executed in multiple trades at prices ranging from $35.50 to 36.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 22:21 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantCommon Stock | 4,609 | $1.29 | $5,925.79 |
DisclosureSEC source: 0000898432-21-000601 · form4.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,877 F1 · price: This option, representing a right to purchase a total of 17,500 shares, was granted on 11/20/2012 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| July 08, 2021 Filed Jul 10, 2021 00:08 UTC | OSI SYSTEMS INC OSIS · Entity 4160 | GrantCommon Stock | 1,960 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-090766 · tm2121298-10_4seq1.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,390 Read SEC document |
| June 26, 2021 Filed Jun 29, 2021 23:18 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 1,268 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-21-000514 · form4.xml · derivative · entry 2 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,268 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: On June 26, 2019, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on June 26, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On June 26, 2019, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on June 26, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| June 26, 2021 Filed Jun 29, 2021 23:18 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 1,268 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-21-000514 · form4.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,268 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 01:01 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 2,185 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-20-000868 · form4.xml · derivative · entry 3 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,185 Underlying: Common Stock · 2,185 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On December 7, 2019, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F4 · derivative.expiration_date: On December 7, 2019, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 01:01 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantRestricted Stock Units · Derivative | 4,074 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-20-000868 · form4.xml · derivative · entry 2 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,370 Underlying: Common Stock · 4,370 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F3 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2021. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F3 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2021. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 01:01 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 2,185 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-20-000868 · form4.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 07, 2020 Filed Jun 29, 2021 23:09 UTC Amendment | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 2,185 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-21-000513 · form4.xml · derivative · entry 3 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,185 Underlying: Common Stock · 2,185 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to common stock on a one-for-one basis. F5 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F5 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2020 Filed Jun 29, 2021 23:09 UTC Amendment | IRADIMED CORP IRMD · Entity 4896 | GrantRestricted Stock Units · Derivative | 4,074 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-21-000513 · form4.xml · derivative · entry 2 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,074 Underlying: Common Stock · 4,074 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F3 · shares: This amendment is being filed to correct the amount of restricted stock units previously reported on the reporting person's Form 4 filed on December 9, 2020. The amount previously reported was 4,370 and it should have been 4,074. F4 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2021. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F4 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2021. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2020 Filed Jun 29, 2021 23:09 UTC Amendment | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 2,185 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-21-000513 · form4.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to common stock on a one-for-one basis. Read SEC document |
| July 20, 2020 Filed Jul 23, 2020 00:14 UTC | Caesars Entertainment, Inc. CZR · Entity 3789 | Exercise / conversionRestricted Stock Unit · Derivative | 2,945 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-020108 · doc4.xml · derivative · entry 12 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,945 shares Expires 2020-07-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. F6 · price: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. Read SEC document |
| July 20, 2020 Filed Jul 23, 2020 00:14 UTC | Caesars Entertainment, Inc. CZR · Entity 3789 | Exercise / conversionRestricted Stock Unit · Derivative | 4,305 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-020108 · doc4.xml · derivative · entry 11 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,305 shares Expires 2020-07-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. F5 · price: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. Read SEC document |
| July 20, 2020 Filed Jul 23, 2020 00:14 UTC | Caesars Entertainment, Inc. CZR · Entity 3789 | Exercise / conversionRestricted Stock Unit · Derivative | 4,612 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-020108 · doc4.xml · derivative · entry 10 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,612 shares Expires 2020-07-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. F4 · price: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. Read SEC document |
| July 20, 2020 Filed Jul 23, 2020 00:14 UTC | Caesars Entertainment, Inc. CZR · Entity 3789 | Exercise / conversionRestricted Stock Unit · Derivative | 6,984 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-020108 · doc4.xml · derivative · entry 9 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,984 shares Expires 2020-07-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. F3 · price: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. Read SEC document |
| July 20, 2020 Filed Jul 23, 2020 00:14 UTC | Caesars Entertainment, Inc. CZR · Entity 3789 | Exercise / conversionRestricted Stock Unit · Derivative | 17,980 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-020108 · doc4.xml · derivative · entry 8 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,980 shares Expires 2020-07-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. F2 · price: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. Read SEC document |
| July 20, 2020 Filed Jul 23, 2020 00:14 UTC | Caesars Entertainment, Inc. CZR · Entity 3789 | Exercise / conversionRestricted Stock Unit · Derivative | 9,256 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-020108 · doc4.xml · derivative · entry 7 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,256 shares Expires 2020-07-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with Eldorado Resorts, Inc. (n/k/a Caesars Entertainment, Inc., the "Company"), all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. F1 · price: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with Eldorado Resorts, Inc. (n/k/a Caesars Entertainment, Inc., the "Company"), all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. Read SEC document |
| July 20, 2020 Filed Jul 23, 2020 00:14 UTC | Caesars Entertainment, Inc. CZR · Entity 3789 | Exercise / conversionCommon Stock | 2,945 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-020108 · doc4.xml · nonDerivative · entry 6 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,082 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. Read SEC document |
| July 20, 2020 Filed Jul 23, 2020 00:14 UTC | Caesars Entertainment, Inc. CZR · Entity 3789 | Exercise / conversionCommon Stock | 4,305 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-020108 · doc4.xml · nonDerivative · entry 5 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,137 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. Read SEC document |
| July 20, 2020 Filed Jul 23, 2020 00:14 UTC | Caesars Entertainment, Inc. CZR · Entity 3789 | Exercise / conversionCommon Stock | 4,612 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-020108 · doc4.xml · nonDerivative · entry 4 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. Read SEC document |
| July 20, 2020 Filed Jul 23, 2020 00:14 UTC | Caesars Entertainment, Inc. CZR · Entity 3789 | Exercise / conversionCommon Stock | 6,984 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-020108 · doc4.xml · nonDerivative · entry 3 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,220 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. Read SEC document |
| July 20, 2020 Filed Jul 23, 2020 00:14 UTC | Caesars Entertainment, Inc. CZR · Entity 3789 | Exercise / conversionCommon Stock | 17,980 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-020108 · doc4.xml · nonDerivative · entry 2 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,236 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. Read SEC document |
| July 20, 2020 Filed Jul 23, 2020 00:14 UTC | Caesars Entertainment, Inc. CZR · Entity 3789 | Exercise / conversionCommon Stock | 9,256 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-020108 · doc4.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with Eldorado Resorts, Inc. (n/k/a Caesars Entertainment, Inc., the "Company"), all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. Read SEC document |
| July 08, 2020 Filed Jul 10, 2020 22:23 UTC | OSI SYSTEMS INC OSIS · Entity 4160 | GrantCommon Stock | 2,795 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-008226 · edgar.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,430 Read SEC document |
| June 26, 2020 Filed Jul 1, 2020 00:57 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 1,268 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-20-000615 · form4.xml · derivative · entry 2 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,268 Underlying: Common Stock · 1,268 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: On June 26, 2019, the reporting person received restricted stock units under the Issuer's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on June 26, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On June 26, 2019, the reporting person received restricted stock units under the Issuer's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on June 26, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| June 26, 2020 Filed Jul 1, 2020 00:57 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 1,268 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-20-000615 · form4.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,815 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2020 Filed Jan 28, 2020 21:53 UTC | Caesars Entertainment, Inc. ERI · Entity 3789 | GrantRestricted Stock Unit · Derivative | 2,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-005171 · doc4.xml · derivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,945 Underlying: Common Stock · 2,945 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: Restricted stock units were granted on January 24, 2020 pursuant to the 2015 Equity Incentive Plan. Reporting person elected to defer vesting until the first to occur of separation of service and a change in control. F2 · derivative.expiration_date: Restricted stock units were granted on January 24, 2020 pursuant to the 2015 Equity Incentive Plan. Reporting person elected to defer vesting until the first to occur of separation of service and a change in control. Read SEC document |
| December 07, 2019 Filed Dec 11, 2019 02:14 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantRestricted Stock Units · Derivative | 4,370 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001417 · form4.xml · derivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,370 Underlying: Common Stock · 4,370 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| September 03, 2019 Filed Sep 3, 2019 22:19 UTC | Caesars Entertainment, Inc. ERI · Entity 3789 | PurchaseCommon Stock | 2,000 | $35.70 | $71,400.00 |
DisclosureSEC source: 0001209191-19-048021 · doc4.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,137 Read SEC document |
| August 23, 2019 Filed Aug 26, 2019 20:33 UTC | Caesars Entertainment, Inc. ERI · Entity 3789 | GrantCommon Stock | 2,000 | $38.20 | $76,400.00 |
DisclosureSEC source: 0001209191-19-047410 · doc4.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,137 Read SEC document |
| August 12, 2019 Filed Aug 12, 2019 23:08 UTC | Caesars Entertainment, Inc. ERI · Entity 3789 | GrantCommon Stock | 2,000 | $39.59 | $79,189.00 |
DisclosureSEC source: 0001209191-19-045632 · doc4.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,137 Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 20:31 UTC | Caesars Entertainment, Inc. ERI · Entity 3789 | PurchaseCommon Stock | 6,000 | $40.35 | $242,070.00 |
DisclosureSEC source: 0001209191-19-045516 · doc4.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,137 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.